Innovative key to product patent in pharmaceutical industry : intellectual property / Jitendra Bhangale and Sanjeev Acharya

By:

Bhangale, Jitendra [author]

Contributor(s):

Acharya, Sanjeev [co-author]

Material type: Text

TextPublication details: Saarbrücken : Lap Lambert Academic Publishing, c2012Description: i, 114 pages ; 23 cmISBN:

9783845471518

Subject(s):

PHARMACEUTICAL INDUSTRY

LOC classification:

RM 301.25 .B43 2012

Contents:

Introduction -- Types of pharmaceutical patent -- Endnotes -- Annex -- References

Summary: This study is primarily about what will happen to important sources of low-cost quality medicines coming from India, an analysis which requires looking at the probable strategic scenariios and options available to firms in these countries.

Item type:

Books

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Home library	Collection	Call number	Copy number	Status	Date due	Barcode
Books	National University - Manila	LRC - Main General Circulation	Pharmacy	GC RM 301.25 .B43 2012 (Browse shelf(Opens below))	c.1	Available		NULIB000014171

Browsing LRC - Main shelves, Shelving location: General Circulation, Collection: Pharmacy Close shelf browser (Hides shelf browser)

Previous								Next
Previous	GC RM 301.14 .L57 1992 Lippincott's illustrated reviews : pharmacology /	GC RM 301.14 .L57 2012 Lippincott's illustrated reviews : pharmacology /	GC RM 301.14 .L57 2015 Lippincott illustrated reviews : pharmacology /	GC RM 301.25 .B43 2012 Innovative key to product patent in pharmaceutical industry : intellectual property /	GC RM 301.25 .B53 2015 Basic principles of drug discovery and development /	GC RM 301.25 .D78 2013 Drug discovery and development /	GC RM 301.25 .D78 2016 Drug utilization research : methods and applications /	Next

Includes bibliographical references.

Introduction -- Types of pharmaceutical patent -- Endnotes -- Annex -- References

This study is primarily about what will happen to important sources of low-cost quality medicines coming from India, an analysis which requires looking at the probable strategic scenariios and options available to firms in these countries.

There are no comments on this title.

to post a comment.